BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 18979141)

  • 1. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
    Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
    Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers.
    Oñate-Ocaña LF; Velázquez-Monroy N; Vázquez L; Espinosa-Mireles-de-Villafranca P; Núñez-Rosas E; Ovando-Lezama M; Vilar-Compte D; García-Hubard G; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Psychooncology; 2012 Jul; 21(7):745-53. PubMed ID: 21538681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
    Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
    Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE; Lari MA; Shandiz FH
    Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
    Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
    Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.